MAZE Maze Therapeutics, Inc.
$31.73▲ +0.13%
Healthcare
Other
After hours
$31.48▼ -0.78%
Oct 28, 4:46 PM ET
Volume 390.8K
Avg Volume (10D) 878.6K
Key Metrics & Fundamentals
Market Cap
$1.76B
P/E Ratio
–
Div Yield
0.00%
52W Range
21.95 - 53.65
% vs 50 MA
15.88%
% vs 200 MA
-0.93%
RSI-14
65.6
MACD Histogram
+0.4300
Beta (1Y vs SPY)
0.71
Free Cash Flow
-$15.16M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$43.41M
COGS
–
Operating Exp
$48.04M
Operating Income
-$48.04M
EBIT
-$48.04M
Pretax Income
-$44.73M
Net Income
-$44.73M
EPS (Diluted)
-0.76
Price & Volume History
Loading chart…
Recent News
What Makes Maze Therapeutics, Inc. (MAZE) a New Buy Stock
Zacks · Oct 19, 2026 11:00 AM ET
Intel upgraded, PayPal downgraded: Wall Street's top analyst calls
The Fly · Oct 19, 2026 9:37 AM ET
How Much Upside is Left in Maze Therapeutics, Inc. (MAZE)? Wall Street Analysts Think 123.39%
Zacks · Oct 19, 2026 8:55 AM ET
Canaccord Genuity Initiates Maze Therapeutics at Buy With $75 Price Target
MT Newswires · Oct 19, 2026 5:37 AM ET
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
PR Newswire · Oct 13, 2026 10:31 AM ET
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
GlobeNewswire · Oct 6, 2026 4:05 PM ET
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight
MarketBeat · Oct 5, 2026 10:55 AM ET
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
Insider Monkey · Sep 28, 2026 8:37 PM ET
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?
Simply Wall St. · Sep 25, 2026 12:23 AM ET
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage
InvestorsHub · Sep 23, 2026 8:48 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See MAZE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.